FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to the field of medicine. In particular the group of inventions relates to the application of an antibody to IL-1β for the treatment and prevention of Familial Mediterranean fever, for the creation of a medication for the treatment of Familial Mediterranean fever, as well as to the pharmaceutical composition.
EFFECT: group of inventions is effective in the prevention and treatment of Familial Mediterranean fever.
11 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW APPLICATION OF IL-1β COMPOUNDS | 2006 |
|
RU2468817C2 |
| NEW INDICATIONS FOR USE IN TREATING ANTIBODIES AGAINST IL-1-BETA | 2014 |
|
RU2698208C2 |
| HUMAN ANTIBODIES TO IL-β1 | 2001 |
|
RU2286351C2 |
| RECOMBINED ANTIBODY TO HUMAN INTERLEUKIN 1β | 2001 |
|
RU2264413C2 |
| ANTIBODIES RAISED TO HUMAN MCP-1 | 2001 |
|
RU2314316C2 |
| IL-18-BINDING PROTEIN (IL-18BP) AND ANTIBODIES IN INFLAMMATORY DISEASES | 2016 |
|
RU2755691C2 |
| IL-18 BINDING PROTEIN (IL-18BP) AND ANTIBODIES IN TREATING INFLAMMATORY DISEASES | 2016 |
|
RU2810206C1 |
| FORMULATIONS CONTAINING ANTIBODIES | 2009 |
|
RU2745601C2 |
| METHOD FOR OBTAINING BI-SPECIFIC ANTIBODIES, BI-SPECIFIC ANTIBODIES AND THERAPEUTIC APPLICATION OF SUCH ANTIBODIES | 2018 |
|
RU2795240C2 |
| GM-CSF-NEUTRALIZING ANTIBODIES FOR USE IN TREATING RHEUMATOID ARTHRITIS OR AS ANALGESICS | 2014 |
|
RU2714919C2 |
